Research and experimental development on natural sciences and engineering
ARCTIC PHARMA AS
Revenue 2025
NOK 1.0m
Operating profit
NOK 135,000
Equity
NOK 2.0m
Incorporated
2012
Share capital
NOK 1.1m
Key figures · 2025
Current ratio
0.82
Equity ratio
69.3%
Key figures over time · 2025
| Key figures | 2025 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | 13.2% | |
| Net margin (%%) | 13.3% | |
| Return on assets (%%) | 4.7% | |
| Likviditet | ||
| Current ratio | 0.82 | |
| Working capital | −80k | |
| Soliditet | ||
| Equity ratio (%%) | 69.3% | |
| Debt-to-equity ratio | 0.44 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.